comparemela.com

Latest Breaking News On - Yichun star - Page 1 : comparemela.com

华仁药业欲取得恒星制药100%股权 标的公司高估值合理性引关注 _ 东方财富网

华仁药业欲取得恒星制药100%股权 标的公司高估值合理性引关注 _ 东方财富网
eastmoney.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eastmoney.com Daily Mail and Mail on Sunday newspapers.

China
Guangxi
Yichun
Heilongjiang
Yulin
Shenzhen
Guangdong
Qujiang
Shandong
Jiangsu
Shenzhen-stock-exchange

华仁药业8亿元收购恒星制药100%股权 _ 东方财富网

华仁药业8亿元收购恒星制药100%股权 _ 东方财富网
eastmoney.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eastmoney.com Daily Mail and Mail on Sunday newspapers.

Anhui
China
Yichun
Heilongjiang
Yulin
Guangxi
Qujiang
Guangdong
States-gordon
Technology-center
Xi-an-qujiang
Poly-star

华仁药业:全资子公司曲江华仁收购恒聚星医药100%股权,并间接持有恒星制药100%股权

华仁药业:全资子公司曲江华仁收购恒聚星医药100%股权,并间接持有恒星制药100%股权
nbd.com.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nbd.com.cn Daily Mail and Mail on Sunday newspapers.

Anhui
China
Yichun
Heilongjiang
Yulin
Guangxi
Qujiang
Guangdong
Technology-center
Qujiang-party
Poly-star

华仁药业(300110.SZ):曲江华仁拟以8亿元收购恒聚星医药100%股权 并间接控股恒星制药_个股资讯_市场_中金在线

华仁药业(300110.SZ):曲江华仁拟以8亿元收购恒聚星医药100%股权 并间接控股恒星制药_个股资讯_市场_中金在线
cnfol.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cnfol.com Daily Mail and Mail on Sunday newspapers.

Anhui
China
Yichun
Heilongjiang
Yulin
Guangxi
Qujiang
Guangdong
Technology-center
Qujiang-china
Poly-star

华仁药业(300110.SZ)拟斥8亿元收购恒聚星医药100%股权以丰富药品品种和研发管线_个股资讯_市场_中金在线

华仁药业(300110.SZ)拟斥8亿元收购恒聚星医药100%股权以丰富药品品种和研发管线_个股资讯_市场_中金在线
cnfol.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cnfol.com Daily Mail and Mail on Sunday newspapers.

Anhui
China
Chile
Yichun
Heilongjiang
Yulin
Guangxi
Qujiang
Guangdong
Technology-center
Qujiang-party

vimarsana © 2020. All Rights Reserved.